BAM
GSK icon

Burgundy Asset Management’s GSK GSK Stock Holding History

Burgundy Asset Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-11,102
Closed -$742K – 110
2014
Q2 		$742K Buy
11,102
+4,008
+56% +$271K 0.01% 98
2014
Q1 		$474K Hold
7,094
– – 0.01% 106
2013
Q4 		$473K Hold
7,094
– – 0.01% 106
2013
Q3 		$445K Hold
7,094
– – 0.01% 101
2013
Q2 		$443K Buy
+7,094
New +$450K 0.01% 106

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Burgundy Asset Management's GSK Position: Q3 2014 in Review

Burgundy Asset Management sold out of GSK (GSK) in Q3 2014, closing a stake of 11,102 shares — an estimated $742K sold.

Burgundy Asset Management first reported a position in GSK in Q2 2013 and held it in 5 quarters. The position peaked at $742K in Q2 2014. 701 funds tracked by Wall St. Rank hold GSK as of Q3 2014.

  • Burgundy Asset Management reported no remaining GSK position as of Q3 2014 after selling out during the quarter.
  • Burgundy Asset Management sold 11,102 GSK shares in Q3 2014, an estimated $742K.
  • Burgundy Asset Management first reported a position in GSK in Q2 2013 and held it in 5 quarters.
  • Burgundy Asset Management's GSK position peaked at $742K in Q2 2014.
  • 701 funds tracked by Wall St. Rank held GSK as of Q3 2014.

Based on Burgundy Asset Management's 13F filing for Q3 2014, filed 14 Nov 2014.